Syndrome of inappropriate antidiuretic hormone history and symptoms: Difference between revisions
No edit summary |
|||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
[[Symptoms]] of SIADH depend on the level of [[sodium]] in the [[blood]] and the rate at which the level of [[sodium]] falls. [[Symptoms]] may be non-specific, such as generalized [[fatigue]] and weakness; but | [[Symptoms]] of SIADH depend on the level of [[sodium]] in the [[blood]] and the rate at which the level of [[sodium]] falls. [[Symptoms]] may be non-specific, such as generalized [[fatigue]] and weakness; but incase of severe disease, [[symptoms]], such as [[irritability]], [[nausea]], [[vomiting]], [[muscle weakness]] and [[cramps]], [[loss of appetite]], [[confusion]], [[personality changes]], [[hallucinations]], [[seizures]], [[stupor]], and [[coma]] may be seen. | ||
==History and Symptoms== | ==History and Symptoms== | ||
*Symptoms vary depending on the | *[[Symptoms]] vary depending on the severity of [[hyponatremia]] and the rate at which [[serum]] [[sodium]] [[concentration]] falls. | ||
*Symptoms of [[SIADH]] include:<ref name="pmid28619670">{{cite journal |vauthors=Spasovski G, Vanholder R, Allolio B, Annane D, Ball S, Bichet D, Decaux G, Fenske W, Hoorn EJ, Ichai C, Joannidis M, Soupart A, Zietse R, Haller M, van der Veer S, van Biesen W, Nagler E, Gonzalez-Espinoza L, Ortiz A |title=Hyponatraemia diagnosis and treatment clinical practice guidelines |journal=Nefrologia |volume=37 |issue=4 |pages=370–380 |year=2017 |pmid=28619670 |doi=10.1016/j.nefro.2017.03.021 |url=}}</ref> | *[[Symptoms]] of [[SIADH]] include:<ref name="pmid28619670">{{cite journal |vauthors=Spasovski G, Vanholder R, Allolio B, Annane D, Ball S, Bichet D, Decaux G, Fenske W, Hoorn EJ, Ichai C, Joannidis M, Soupart A, Zietse R, Haller M, van der Veer S, van Biesen W, Nagler E, Gonzalez-Espinoza L, Ortiz A |title=Hyponatraemia diagnosis and treatment clinical practice guidelines |journal=Nefrologia |volume=37 |issue=4 |pages=370–380 |year=2017 |pmid=28619670 |doi=10.1016/j.nefro.2017.03.021 |url=}}</ref> | ||
**[[Nausea]] and [[vomiting]] | **[[Nausea]] and [[vomiting]] | ||
**[[Loss of appetite]] | **[[Loss of appetite]] |
Revision as of 20:30, 15 November 2017
Syndrome of inappropriate antidiuretic hormone Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Syndrome of inappropriate antidiuretic hormone history and symptoms On the Web |
American Roentgen Ray Society Images of Syndrome of inappropriate antidiuretic hormone history and symptoms |
FDA on Syndrome of inappropriate antidiuretic hormone history and symptoms |
CDC on Syndrome of inappropriate antidiuretic hormone history and symptoms |
Syndrome of inappropriate antidiuretic hormone history and symptoms in the news |
Blogs on Syndrome of inappropriate antidiuretic hormone history and symptoms |
Directions to Hospitals Treating Syndrome of inappropriate antidiuretic hormone |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vindhya BellamKonda, M.B.B.S [2]
Overview
Symptoms of SIADH depend on the level of sodium in the blood and the rate at which the level of sodium falls. Symptoms may be non-specific, such as generalized fatigue and weakness; but incase of severe disease, symptoms, such as irritability, nausea, vomiting, muscle weakness and cramps, loss of appetite, confusion, personality changes, hallucinations, seizures, stupor, and coma may be seen.
History and Symptoms
- Symptoms vary depending on the severity of hyponatremia and the rate at which serum sodium concentration falls.
- Symptoms of SIADH include:[1]
- Nausea and vomiting
- Loss of appetite
- Fatigue and weakness
- Irritability
- Personality changes, such as combativeness
- Seizures
- Confusion
- Hallucinations
- Stupor
- Coma
References
- ↑ Spasovski G, Vanholder R, Allolio B, Annane D, Ball S, Bichet D, Decaux G, Fenske W, Hoorn EJ, Ichai C, Joannidis M, Soupart A, Zietse R, Haller M, van der Veer S, van Biesen W, Nagler E, Gonzalez-Espinoza L, Ortiz A (2017). "Hyponatraemia diagnosis and treatment clinical practice guidelines". Nefrologia. 37 (4): 370–380. doi:10.1016/j.nefro.2017.03.021. PMID 28619670.